Navigation Links
Health study in northern Uganda calls for improved services for internally displaced persons
Date:11/24/2008

There are over 1 million internally displaced persons (IDPs) in Uganda due to the 20-year conflict waged between a rebel group, the Lord's Resistance Army, and the central government.

Previous research on the health of IDPs has focused on specific physical and mental health conditions, but a study just published in the 'online first' section of the Journal of Epidemiology and Community Health (http://jech.bmj.com/onlinefirst.dtl) and led by Bayard Roberts of the London School of Hygiene & Tropical Medicine (LSHTM)'s Conflict and Health Programme, and Dr. Felix Ocaka of the Faculty of Medicine at Gulu University, Uganda, has for the first time sought to examine the determinants of general health among IDPs, including the physical, mental, emotional and social characteristics of health.

The authors carried out a cross-sectional survey in November 2006 with 1206 IDPs in 28 IDP camps in Gulu and Amuru districts of northern Uganda. Interviewees were asked questions from the SF-8 instrument to measure how they rated their general health. Interviewees were also asked questions on factors affecting health status, such as gender, age, educational level, number of people in the household, access to latrines, water and hygiene, health services, food security, alcohol intake, history of displacement, exposure to violent and traumatic events and sense of safety in the camps.

Variables which had a significant negative effect on physical or mental health included gender, age, marital status, income, distance of camp from home areas, food security, use of soap, and sense of safety in the camp. A number of individual trauma variables and the frequency of trauma exposure also had negative associations with both physical and mental health. The use of family for emotional support showed a positive association with better mental health.

Bayard Roberts, Research Fellow in Conflict & Health at LSHTM, co
'/>"/>

Contact: Gemma Howe
gemma.howe@lshtm.ac.uk
020-792-72802
London School of Hygiene & Tropical Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. CVS Caremark Named Finalist in URAC Annual Best Practices in Health Care Consumer Empowerment and Protection Awards
2. Collexis Launches Innovative Reviewer Finder to Enhance the $30 Billion Health Research Grant Industry
3. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
4. Holiday Health Tips From Packard Childrens Hospital
5. Everything Channels Vision Events Announces the Winners of the Healthcare IT Innovation(TM) Awards
6. The Female Health Company Schedules Year End FY2008 Conference Call for December 1, 2008
7. Accuray Incorporated to Present at 20th Annual Piper Jaffray Health Care Conference
8. New Consumer Health Guide -- Pass Up the Poison Plastic, The PVC-Free Guide for Your Family & Home Released Just in Time for the Holiday Shopping Season
9. Lilly Receives NCQA Health Information Product Certification for Interactive Online Health Education Answers Program
10. Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
11. Accordia Global Health Foundation Receives $12.5 Million Grant From Bill & Melinda Gates Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...- Recent news reports have highlighted the importa...sicians meet high standards in their chosen area o...ical Specialties (ABMS), which coordinates and ass...lop and implement educational and professional sta...sician specialists. Certification by an ABMS Memb...
(Date:7/2/2009)...- Pro-life forces won an important battle yesterda...ate law regulating that abortion centers must prop... (also known as the "abortion pill") in order to p... The ruling came in Rogers v. Planned Parenthood ...requiring that those administering RU-486 comply w...
(Date:7/2/2009)... in Washington, D.C. , , ARLINGTON, Texas, Jul...urces has received the Best Employers for Healthy...p on Health. , , (Logo: http://www.newscom.c...he award recognizes the nation,s leading corporati... workplace and for helping employees and their fam...
(Date:7/2/2009)...t, expert says , , THURSDAY, July 2 (Hea...n species of wildlife, which need to be protected ...Cancer is one of the leading health concerns for h...n deaths. But we now understand that cancer can ki...ise McAloose, chief pathologist for the Wildlife C...
Breaking Medicine News(10 mins):Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Cancer Endangers Some Wildlife Species 2
...afe and cost-effective dipstick for the early dete... cost, sensitivity and ease of// use make it bette... and colleagues at the India-based Defence Researc...ed a way to efficiently produce a protein that the...
...eek of sun, snow, and après-ski. And while they ma...e dangers of skin// cancer? It is one of the most...ew cases reported every year. The incidences of th...anoma – have has doubled over the past 20 years. ...
...e first medical centers in the country, and curren...novel clinical trial to// determine if a subject’s...y artery disease. The Autologous Cellular Therapy...4-CMI) Trial is the first human, Phase II adult st...
...es on anti-AIDS vaginal gel in Africa and India, f...// that it could enhance the risk of HIV infection...lled Ushercell, contains a cotton-based compound c...eveloped by Polydex Pharmaceuticals, a company in ...
Other Medicine News:Health News:The Psychology of Skin Cancer 2Health News:Potential for Adult Stem Cells to Repair Hearts Damaged Investigated 2Health News:Potential for Adult Stem Cells to Repair Hearts Damaged Investigated 3
(Date:7/1/2009)...nmark, July 1 A just pub...on Investigational Drugs", Volume,18, Issue 7 200...,PROSTVAC(TM). This is the most comprehensive and ...uote from the article: "Preliminary clinical trial...I trials have suggested a survival benefit,after ...
(Date:6/30/2009)... Calixa Therapeutics Inc. today an... of CXA-101 in patients with complicated urinary t... parenteral cephalosporin antibiotic with excellen...omonas aeruginosa , including drug resistant isola...al treatment for serious bacterial infections in h...
(Date:6/29/2009)...s for Novel Biotherapeutics Based On Naturally Res... Pangu BioPharma, a subsidiary of a...g of its third patent application on proprietary, ...es. Although tRNA synthetases are universal and e... found in all organisms, human synthetases have na...
(Date:6/26/2009)...une 26, and OSAKA, Japan, June 27, 2009 /PRNewswir...da") today announced that Takeda Global Research &...ed States (U.S.) subsidiary received on June 26 (U... Food and Drug Administration (FDA) regarding the ...n, a selective dipeptidyl peptidase IV (DPP-4) inh...
Breaking Medicine Technology:New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2Hologic to Present at the J P Morgan 27th Annual Healthcare Conference 31469 1Hologic to Present at the J P Morgan 27th Annual Healthcare Conference 31469 2Poor Mental Health May Boost Asthma Risk 31467 1Poor Mental Health May Boost Asthma Risk 31467 2REGiMMUNE to present GvHD data at the 50th ASH Annual Meeting 31464 1The SCOOTER Store Donates Power Wheelchair to Texas Teenager With Rare Genetic Disorders 31463 1The SCOOTER Store Donates Power Wheelchair to Texas Teenager With Rare Genetic Disorders 31463 2The SCOOTER Store Donates Power Wheelchair to Texas Teenager With Rare Genetic Disorders 31463 3
...Serial Outpatient Infusion Study in Patients with,...he American,College of Cardiology 56th Annual Scie...RLEANS, March 25, 2007,/PRNewswire/ -- Scios Inc. ...Phase 2 study of nesiritide (NATRECOR(R)) showed a...te of death and,cardiorenal hospitalization at 12 ...
....J., March 25, 2007 /PRNewswire/ -- Once-daily,dos...tolvaptan, a,vasopressin receptor antagonist, was ... of acutely decompensated heart failure (ADHF),in ... without an,adverse effect on their long-term surv...ort- and long-term analyses of the,international l...
Other Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: